Cargando…
Agranulocytosis Following COVID-19 Recovery
Clinicians have continued to report on the clinical behavior and characteristics of patients with coronavirus disease 2019 (COVID-19) as our knowledge of the virus continues to mature. Herein, we report the case of a 39-year-old male with multiple comorbidities who became critically ill with COVID-1...
Autores principales: | Lutfi, Forat, Benyounes, Amin, Farrukh, Naveed, Bork, Jacqueline, Duong, Vu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455389/ https://www.ncbi.nlm.nih.gov/pubmed/32874794 http://dx.doi.org/10.7759/cureus.9463 |
Ejemplares similares
-
Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
por: Munir, Farrukh, et al.
Publicado: (2022) -
A Case of Sudden Very Late Onset of Severe Clozapine-induced Agranulocytosis Following an Influenza Vaccine
por: Jean, Soluny, et al.
Publicado: (2019) -
A Case Report on Metamizole-Induced Agranulocytosis: Is the Benefit Worth the Risk?
por: Carvalho, Rita, et al.
Publicado: (2023) -
Low-Dose Quetiapine Causing Agranulocytosis and Leucopenia in a Patient with Benign Neutropenia: A Case Report
por: Fryer, Vincent, et al.
Publicado: (2020) -
Agranulocytosis Secondary to Cancer Chemotherapy Associated With Higher In-Hospital Mortality in Patients With Central Line Insertion During a Hospital Stay
por: Mohamed Jiffry, Mohamed Z, et al.
Publicado: (2023)